Clorox (NYSE:CLX) Upgraded at StockNews.com

Clorox (NYSE:CLX) was upgraded by analysts at StockNews.com from a “hold” rating to a “buy” rating in a report issued on Wednesday.

Several other analysts have also recently issued reports on CLX. TD Cowen raised shares of Clorox from a “sell” rating to a “hold” rating and increased their price target for the stock from $155.00 to $170.00 in a research report on Wednesday, November 6th. Jefferies Financial Group raised shares of Clorox from a “hold” rating to a “buy” rating and upped their target price for the stock from $174.00 to $187.00 in a research note on Tuesday, October 1st. Evercore ISI decreased their price target on shares of Clorox from $140.00 to $139.00 and set an “underperform” rating for the company in a research report on Monday, October 14th. DA Davidson upped their price objective on Clorox from $153.00 to $171.00 and gave the stock a “neutral” rating in a research report on Monday, November 4th. Finally, BNP Paribas upgraded Clorox to a “strong sell” rating in a report on Friday, September 6th. Five analysts have rated the stock with a sell rating, eight have issued a hold rating and two have assigned a buy rating to the stock. Based on data from MarketBeat, the stock has an average rating of “Hold” and a consensus price target of $155.38.

Clorox Trading Down 1.0 %

NYSE CLX traded down $1.60 on Wednesday, reaching $161.72. The stock had a trading volume of 1,257,557 shares, compared to its average volume of 1,229,756. The company has a quick ratio of 0.62, a current ratio of 1.00 and a debt-to-equity ratio of 11.08. The stock has a fifty day moving average price of $163.96 and a two-hundred day moving average price of $152.40. Clorox has a 12-month low of $127.60 and a 12-month high of $171.37. The firm has a market capitalization of $20.02 billion, a price-to-earnings ratio of 56.35, a P/E/G ratio of 3.04 and a beta of 0.42.

Clorox (NYSE:CLX) last issued its quarterly earnings data on Wednesday, October 30th. The company reported $1.86 earnings per share for the quarter, beating analysts’ consensus estimates of $1.36 by $0.50. Clorox had a return on equity of 316.08% and a net margin of 4.78%. The business had revenue of $1.76 billion during the quarter, compared to analysts’ expectations of $1.64 billion. During the same period in the previous year, the firm posted $0.49 earnings per share. The company’s revenue was up 27.0% on a year-over-year basis. As a group, sell-side analysts forecast that Clorox will post 6.85 EPS for the current fiscal year.

Institutional Investors Weigh In On Clorox

Several hedge funds and other institutional investors have recently made changes to their positions in CLX. Prospera Private Wealth LLC purchased a new position in Clorox in the third quarter valued at approximately $27,000. Innealta Capital LLC purchased a new position in shares of Clorox in the 2nd quarter valued at $30,000. Trifecta Capital Advisors LLC raised its stake in Clorox by 139.8% during the 2nd quarter. Trifecta Capital Advisors LLC now owns 223 shares of the company’s stock worth $30,000 after acquiring an additional 130 shares in the last quarter. Continuum Advisory LLC raised its stake in Clorox by 300.0% during the 3rd quarter. Continuum Advisory LLC now owns 184 shares of the company’s stock worth $30,000 after acquiring an additional 138 shares in the last quarter. Finally, Family Firm Inc. purchased a new stake in Clorox in the second quarter valued at $31,000. Institutional investors and hedge funds own 78.53% of the company’s stock.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.